Hybrid gold nanorod-based nanoplatform with chemo and photothermal activities for bimodal cancer therapy

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Física de Partículas
dc.contributor.authorArellano, Lilia G.
dc.contributor.authorVillar Álvarez, Eva
dc.contributor.authorVarela, Alejandro
dc.contributor.authorFigueroa, Valeria
dc.contributor.authorFernández Vega, Javier
dc.contributor.authorCambón Freire, Adriana
dc.contributor.authorPrieto Estévez, Gerardo
dc.contributor.authorBarbosa Fernández, Silvia
dc.contributor.authorTaboada Antelo, Pablo
dc.date.accessioned2025-11-21T07:41:24Z
dc.date.available2025-11-21T07:41:24Z
dc.date.issued2022-10-28
dc.description.abstractMetal nanoparticles (NPs), particularly gold nanorods (AuNRs), appear as excellent platforms not only to transport and deliver bioactive cargoes but also to provide additional therapeutic responses for diseased cells and tissues and/or to complement the action of the carried molecules. In this manner, here, we optimized a previous developed metal-based nanoplatform composed of an AuNR core surrounded by a polymeric shell constructed by means of the layer-by-layer approach, and in which very large amounts of the antineoplasic drug doxorubicin (DOXO) in a single loading step and targeting capability thanks to an outer hyaluronic acid layer were incorporated by means of an optimized fabrication process (PSS/DOXO/PLL/HA-coated AuNRs). The platform retained its nanometer size with a negative surface charge and was colloidally stable in a range of physiological conditions, in which only in some of them some particle clustering was noted with no precipitation. In addition, the dual stimuli-responsiveness of the designed nanoplatform to both endogenous proteases and external applied light stimuli allows to perfectly manipulate the chemodrug release rates and profiles to achieve suitable pharmacodynamics. It was observed that the inherent active targeting abilities of the nanoplatfom allow the achievement of specific cell toxicity in tumoral cervical HeLa cells, whilst healthy ones such as 3T3-Balb fibroblast remain safe and alive in agreement with the detected levels of internalization in each cell line. In addition, the bimodal action of simultaneous chemo- and photothermal bioactivity provided by the platform largely enhances the therapeutic outcomes. Finally, it was observed that our PSS/DOXO/PLL/HA-coated AuNRs induced cell mortality mainly through apoptosis in HeLa cells even in the presence of NIR light irradiation, which agrees with the idea of the chemo-activity of DOXO predominating over the photothermal effect to induce cell death, favoring an apoptotic pathway over necrosis for cell death.
dc.description.peerreviewedSI
dc.identifier.citationArellano-Galindo, L.; Villar-Alvarez, E.; Varela, A.; Figueroa, V.; Fernandez-Vega, J.; Cambón, A.; Prieto, G.; Barbosa, S.; Taboada, P. Hybrid Gold Nanorod-Based Nanoplatform with Chemo and Photothermal Activities for Bimodal Cancer Therapy. Int. J. Mol. Sci. 2022, 23, 13109. https://doi.org/10.3390/ijms232113109
dc.identifier.doi10.3390/ijms232113109
dc.identifier.essn1422-0067
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/10347/43956
dc.issue.number21
dc.journal.titleInternational Journal of Molecular Sciences
dc.language.isoeng
dc.publisherMDPI
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-109517RB-I00/ES/NUEVOS NANOTRANSPORTADORES BIOMIMETICOS YPLATAFORMAS IN VITRO PARA LA VALIDACION EXITOSA DE LA TERAGNOSTICA PARA LA ATEROSCLEROSIS
dc.relation.publisherversionhttps://doi.org/10.3390/ijms232113109
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectGold nanorods
dc.subjectLayer assembly
dc.subjectPhotothermal therapy
dc.subjectMultimodal therapy
dc.subjectCell death pathway
dc.titleHybrid gold nanorod-based nanoplatform with chemo and photothermal activities for bimodal cancer therapy
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number23
dspace.entity.typePublication
relation.isAuthorOfPublicationb424617d-acc8-4bf0-bfa3-4530b6af61af
relation.isAuthorOfPublication80e0156c-91f5-4211-b8d2-1943075afa6c
relation.isAuthorOfPublicationc9b6a5e5-adf1-4428-8027-3a2e86155477
relation.isAuthorOfPublicationabcc51d3-7eba-4623-a29a-bbd9b0a7874f
relation.isAuthorOfPublication.latestForDiscoveryb424617d-acc8-4bf0-bfa3-4530b6af61af

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
SILVIA5.pdf
Size:
5.19 MB
Format:
Adobe Portable Document Format